Hypertension and heart failure: Role of neurohormonal mechanisms

Clinical and Experimental Hypertension

Volumn 26, Issue 7-8, 2004, Pages 603-610

  Volpe, Massimo ^a,b   Pagannone, E ^a   Tocci, G ^a   Rubattu, S ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

Angiotensin II; Blood pressure; Natriuretic peptides; Ventricular function

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; NEUROHORMONE; NORADRENALIN; RENIN;

CONFERENCE PAPER; DISEASE COURSE; FLUID BALANCE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEMODYNAMICS; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; NEUROENDOCRINOLOGY; PATHOGENESIS; PATHOPHYSIOLOGY; SODIUM BALANCE;

HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; NEUROTRANSMITTER AGENTS;

EID: 12344284745     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-200031916     Document Type: Conference Paper

References (26)

1. Kannel WB, Ho K, Thom, T. Changing epidemiological features of cardiac failure. Br Heart J 1994; 72(suppl):S3-S9.
2. The task force for the diagnosis and treatment of chronic heart failure, European Society of cardiology. Eur Heart J 2001; 22:1527-1560.
3. Francis GS, Rector TS, Cohn JN. Sequential neurohumoral measurements in patients with congestive heart failure. Am Heart J 1988; 116:1464-1468.
4. Schrier RW, Abraham WT. Hormones and haemodynamics in heart failure. N Engl J Med 1999; 341:577-585.
5. Kjær B, Hesse. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clin Physiol 2001; 21(6):661-672.
6. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1991; 327:1667.
7. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325:293-302.
8. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, The SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992; 327:669-677.
9. The CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001; 357:1385-1390.
10. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J, Randomized Aldactone Evaluation Study Investigators (RALES). The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341:709-717.
11. Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B, The Losartan Heart Failure Survival Study (ELITE II) Investigators. Effect of Losartan compared with Captopril on mortality in patients with symptomatic heart failure: a randomized trial. Lancet 2000; 355:1582-1587.
12. Volpe M, Rao M, Tritto C, Pisani A, Mele A, Enea I, Condorelli M. Transition from asymptomatic left ventricular dysfunction to congestive heart failure. J Card Fail 1995; 1(5):409-419.
13. Volpe M, Magri P, Rao MAE, Cangianiello S, De Luca N, Mele AF, Memoli B, Enea I, Rubattu S, Gigante B, Trimarco B, Condorelli M. Intrarenal determinants of sodium retention in mild heart failure. Hypertension 1997; 30:168-176.
14. Magri P, Rao MAE, Cangianiello S, Bellizzi V, Russo R, Mele ALF, Andreucci M, Memoli B, De Luca N, Volpe M. Early impairment of renal hemodinamic reserve in patients with asyntomatic heart failure is restored by angiotensin II antagonism. Circulation 1998; 98:2849-2854.
15. Volpe M, Tritto C, De Luca N, Mele AF, Lembo G, Rubattu S, Romano M, De Campora P, Enea I, Ricciardelli B, Trimarco B, Condorelli M. Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure. J Clin Invest 1991; 88:1481-1489.
16. Volpe M, Tritto C, DeLuca N, Rubattu S, Mele A, Lembo G, Enea I, De Campora P, Rendina P, Romano M, Trimarco B, Condorelli M. Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure. Circulation 1992; 86:1800-1809.
17. Volpe M, Tritto C, DeLuca N, Rubattu S, Rao M, Lamenza F, Mirante A, Enea I, Rendina V, Mele A, Trimarco B, Condorelli M. Abnormalities of sodium handing and of cardiovascular adaptations during high salt diet in patients with mild heart failure. Circulation 1993; 88:1620-1627.
18. Volpe M, Lembo G, De Luca N, Lamenza F, Tritto C, Ricciardelli B, Molaro M, De Campora P, Condorelli G, Rendina V. Abnormal hormonal and renal responses to saline load in hypertensive patients with parental history of cardiovascular accidents. Circulation 1991; 84:92-100.
19. Rubattu S, Volpe M. The atrial natriuretic peptide: a changing view. J Hypertens 2001; 19:1923-1931.
20. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339:321-328.
21. Briguori C, Betocchi S, Manganelli F, Gigante B, Losi MA, Ciampi Q, Gottilla R, Violante A, Tocchetti CG, Volpe M, Chiariello M. Determinants and clinical significance of natriuretic peptides and hypertrophic cardiomyopathy. Eur Heart J 2001; 22(15):1328-1336.
22. Krum H, Roecker EB, Mohacsi P, Rouleau JL, Tendera M, Coats AJ, Katus HA, Fowler MB, Packer M. Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study. JAMA 2003; 289(6):712-718.
23. Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, Torp-Pedersen C, Ball S, Pogue J, Moye L, Braunwald for the ACE-Inhibitor Myocardial Infarction Collaborative Group E. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet 2000; 355:1575-1581.
24. Garg R, Yusuf S, Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA May 10, 1995; 273(18):1450-1456.
25. Cohn JN, Tagnoni G, Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin II receptor blocker Valsartan in congestive heart failure (Val-HeFT). N Engl J Med 2001; 345:1667-1675.
26. Ruschitzka FT. Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat vs. enalapril randomized trial of utility in reducing events (OVERTURE). Curr Hypertens Rep Feb 2003; 5(1):57-58.